HA
NSPR icon

Huntleigh Advisors’s InspireMD NSPR Stock Holding History

Huntleigh Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-264,004
Closed -$636K – 288
2025
Q3 		$636K Buy
264,004
+139,776
+113% +$339K 0.11% 150
2025
Q2 		$282K Buy
124,228
+6,821
+6% +$17K 0.05% 215
2025
Q1 		$316K Buy
+117,407
New +$332K 0.07% 182

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Huntleigh Advisors's NSPR Position: Q4 2025 in Review

Huntleigh Advisors sold out of InspireMD (NSPR) in Q4 2025, closing a stake of 264,004 shares — an estimated $636K sold.

Huntleigh Advisors first reported a position in NSPR in Q1 2025 and held it in 3 quarters. The position peaked at $636K in Q3 2025. 45 funds tracked by Wall St. Rank hold NSPR as of Q4 2025.

  • Huntleigh Advisors reported no remaining InspireMD position as of Q4 2025 after selling out during the quarter.
  • Huntleigh Advisors sold 264,004 InspireMD shares in Q4 2025, an estimated $636K.
  • Huntleigh Advisors first reported a position in InspireMD in Q1 2025 and held it in 3 quarters.
  • Huntleigh Advisors's InspireMD position peaked at $636K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held InspireMD as of Q4 2025.

Based on Huntleigh Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.